Comment Regarding "Comparative Effectiveness of Anti-TNF in Combination With Low-Dose Methotrexate vs Anti-TNF Monotherapy in Pediatric Crohn's Disease: A Pragmatic Randomized Trial" Reply

被引：0
|
作者：
Kappelman, Michael D. [1 ]
Saeed, Shehzad A. [2 ]
Bousvaros, Athos [3 ]
机构：
[1] Univ N Carolina, Chapel Hill, NC 27515 USA
[2] Dayton Childrens Hosp, Dayton, OH USA
[3] Boston Childrens Hosp, Boston, MA USA
来源：
GASTROENTEROLOGY | 2023年 / 165卷 / 05期
关键词：
D O I：
10.1053/j.gastro.2023.08.023
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1308 / 1308
页数：1
相关论文
共 50 条
  • [21] Addition of thiopurine can recapture lost response to anti-TNF monotherapy in Crohn's disease
    Ong, David E.
    Lust, Mark
    Kamm, Michael A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 113 - 113
  • [22] Addition of thiopurine can recapture lost response to anti-tnf monotherapy in Crohn's disease
    Ong, David
    Lust, Mark
    Kamm, Michael
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 158 - 158
  • [23] Anti-TNF therapies have eliminated the need for steroids in pediatric Crohn's disease
    Grand, RJ
    INFLAMMATORY BOWEL DISEASES, 2001, 7 (04) : 345 - 346
  • [24] Effectiveness of ustekinumab in fistulising perianal Crohn's disease refractory or intolerant to anti-TNF
    Carpio, D.
    Calvino-Suarez, C.
    Martinez-Cadilla, J.
    Molina, G.
    Vazquez-Rey, M. T.
    Marti, E.
    Fernandez-Salgado, E.
    Acosta, M. Barreiro-de
    Hernandez, V.
    Echarri, A.
    Diz-Lois, M. T.
    Baz, A.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S419 - S420
  • [25] Adalimumab as first-line anti-TNF treatment in pediatric Crohn's disease
    Martin-de-Carpi, J.
    Navas-Lopez, V. M.
    Navalon-Rubio, M.
    Llerena-Santa-Cruz, E.
    Gil-Ortega, D.
    Varea-Calderon, V.
    Sierra-Salinas, C.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S309 - S309
  • [26] Adalimumab As First-Line Anti-TNF Treatment in Pediatric Crohn's Disease
    Martin-de-Carpi, Javier
    Navas-Lopez, Victor
    Navalon-Rubio, Maria
    Llerena-Santa-Cruz, Enrique
    Ortega, David Gil
    Varea-Calderon, Vicente
    Sierra-Salinas, Carlos
    GASTROENTEROLOGY, 2014, 146 (05) : S780 - S780
  • [27] ANTI-TNF ALPHA THERAPY AND MUCOSAL HEALING IN A PEDIATRIC CROHN'S DISEASE POPULATION
    Nuti, F.
    Civitelli, F.
    Di Nardo, G.
    Bloise, S.
    Dilillo, A.
    Aloi, M.
    Viola, F.
    Cucchiara, S.
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : S9 - S9
  • [28] Real-World Anti-TNF Dose Escalation in Patients With Crohn's Disease
    Rubin, David T.
    Kane, Sunanda
    Jaganathan, Srihari
    Palmer, Liisa
    Cyhaniuk, Anissa
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2015, 7 (05) : E135 - E140
  • [29] Effectiveness of a Dose "De-Escalation" Strategy With Anti-TNF Drugs in Patients With Crohn's Disease (CD)
    Chaparro, Maria
    Acosta, Manuel Barreiro-de
    Garcia-Planella, Esther
    Domenech, Eugeni
    Bennejo, Fernando
    Calvet, Xavier
    Arranz, Maria Dolores Martin
    Monforn, David
    Gisbert, Javier P.
    GASTROENTEROLOGY, 2011, 140 (05) : S590 - S590
  • [30] Treatment of Perianal Fistulas in Crohn's Disease, Seton Versus Anti-TNF Versus Surgical Closure Following Anti-TNF [PISA]: A Randomised Controlled Trial
    Wasmann, Karin A.
    de Groof, E. Joline
    Stellingwerf, Merel E.
    D'Haens, Geert R.
    Ponsioen, Cyriel Y.
    Gecse, Krisztina B.
    Dijkgraaf, Marcel G. W.
    Gerhards, Michael F.
    Jansen, Jeroen M.
    Pronk, Apollo
    van Tuyl, Sebastiaan A. C.
    Zimmerman, David D. E.
    Bruin, Karlien F.
    Spinelli, Antonino
    Danese, Silvio
    van der Bilt, Jarmila D. W.
    Mundt, Marco W.
    Bemelman, Willem A.
    Buskens, Christianne J.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 (08): : 1049 - 1056
12345